Le Lézard
Classified in: Health, Sports and recreation
Subjects: NPT, OBI


CHICAGO, Jan. 11, 2024 /PRNewswire/ -- The Alzheimer's Association is deeply saddened by the death of New York Mets legend and Hall of Famer Bud Harrelson. Mr. Harrelson and his family bravely revealed his Alzheimer's diagnosis in 2018. Following his diagnosis, Harrelson was a devoted advocate for the cause, sharing his story publicly to raise awareness and funds for Alzheimer's research and care and support programs.

Mr. Harrelson and his family regularly partnered with the Alzheimer's Association to help reduce stigma surrounding Alzheimer's disease and elevate the conversation on behalf of the millions of families facing the disease. In 2018, Harrelson was an honorary chair for the Alzheimer's Association Long Island Chapter Walk to End Alzheimer's. The following year, he joined the Long Island Chapter's Board of Directors.

"The Alzheimer's Association mourns the loss of New York Mets legend Bud Harrelson," said Joanne Pike, DrPH, president and CEO, Alzheimer's Association. "Mr. Harrelson was a champion both on and off the field. Together with his family, he bravely shared his Alzheimer's diagnosis to increase awareness and inspire change. For the Harrelson family, and the millions of others impacted by Alzheimer's and dementia, we will remain relentless in our work of increasing awareness, providing support, and accelerating research and treatments, to slow, stop and ultimately, cure Alzheimer's disease."

According to the Alzheimer's Association 2023 Alzheimer's Disease Facts and Figures report, more than 6 million Americans are currently living with Alzheimer's disease, with more than 11 million friends and family providing unpaid care. These numbers will skyrocket in the coming years and by 2050, the number of people with Alzheimer's disease is projected to double.

About the Alzheimer's Association®
The Alzheimer's Association is a worldwide voluntary health organization dedicated to Alzheimer's care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia ? by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.

SOURCE Alzheimer's Association

These press releases may also interest you

at 05:15
The Industrial Technology Research Institute (ITRI) triumphed at the recent Edison Awardstm in Fort Myers, Florida, securing recognition for four exceptional technological breakthroughs: the Novel Dual-Targeted Therapy for Glaucoma, Key Functional...

at 05:00
The Beta-Glucan Market is estimated at USD 542 million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from 2024 to 2029 according to a report published by MarketsandMarketstm. The growth of the beta-glucan market is...

at 05:00
Geekplus, the global leader in mobile robot and smart logistics solutions, has deployed the first Shelf-to-Person PopPick project in the Nordics for one of the biggest online pharmacy wholesalers in the region, Med24.dk. System Teknik partnered on...

at 04:58
Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Nano Letters how the use of high-speed atomic force microscopy helps to understand the crucial role played by certain biomolecules in DNA wrapping dynamics. In...

at 04:00
Bioforum, the Data Masters, a leading contract research organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry, today announced the launch of SUBMIT24 in its beta version during Q3 2024,...

at 04:00
TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and...

News published on and distributed by: